ObjectivesThe aim of this study was to evaluate safety and seroconversion when an inactivated H3N2 canine influenza virus (CIV) vaccine was administered to cats.MethodsTwenty 7–8-week-old seronegative cats were randomly assigned to two groups of 10 …